TED Ted Baker Plc

 

TIDMTED TIDMCRD 
 
RNS Number : 0108N 
Tepnel Life Sciences PLC 
09 February 2009 
 
Tepnel Life Sciences Plc ("the Company") 
 
 
Holding in Company 
 
 
The Company was informed on the 06 February 2009, that following the purchases 
of Ordinary shares on 05 February 2009 by Credit Suisse Group ('CSG'), CSG has a 
notifiable interest of 16,947,500 ordinary shares in the Company, representing 
approximately 6.95% of the issued share capital of the Company. 
 
 
For further information: 
 
 
Tepnel Life Sciences plc 
Ben Matzilevich, Chief Executive Officer 
Michael Slater, Group Finance Director 
Carol Smith, Group Marketing Communications Manager 
Tel: 0161 946 2200 
 
 
Capital MS&L 
Mary Clark or Joanna Whineray 
Tel: +44 20 7307 5330 
 
 
Seymour Pierce Limited 
Mark Percy 
Tom Sheldon 
Christopher Wren 
Tel: +44 20 7107 8000 
 
 
Notes to Editors: 
 
 
About Tepnel Life Sciences plc 
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences 
products and services Group with two divisions, Molecular Diagnostics and 
Research Products & Services. The Company has laboratories, manufacturing and 
operations in the USA, UK and France with over 200 employees. Tepnel provides 
test kits, reagents and services to two highly synergistic markets, these being 
Molecular Diagnostics and Biomedical Research. The Company's strategy has been 
to identify high growth niche opportunities within these multi-billion pound 
markets. Tepnel focuses on these niche operations with internally developed 
products, patents, expertise and know-how as well as strategic acquisitions, to 
develop a leadership position within these 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 HOLUKUURKSRURAR 
 

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024